Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: January 2022

1/27/2022 Database Update: Audit of Veterinary Drug Retail Sales in Russia (December 2021)

In 2021, the sales of veterinary drugs in the Russian retail market amounted to 21.1 billion rubles (retail prices, VAT included), up 4% from 2020. While that seems to be a fine result, especially considering the growth rates of –0.3% in 2020, it is obvious that the inflation rate influenced the growth rates in 2021. In physical terms, the growth rates kept falling (–7.2% in monetary dosage units, or MDUs), and the total sales volume was 166.7 million MDUs.

1/26/2022 Database Update: Audit of Veterinary Drug Retail Sales on Russian Online Marketplaces (December 2021)

In 2021, the retail sales of veterinary drugs through the top online marketplaces in Russia amounted to 727.6 million rubles (retail prices, VAT included), having tripled from 2020. In physical terms, the sales increased 2.5 times from 2020, if calculated in minimum dosage units (MDU). The sales volume was 5.1 million MDUs.

1/25/2022 Survey by RNC Pharma and Medvestnik: 19% of Russian Doctors Ready to Report Vaccine-Hesitant Co-workers to Management

40% of Russian doctors do not accept “workplace snitching” in any case, according to a survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik. Obviously, this answer had statistically significant differences between the two types of medical institutions—it was more often chosen by employees of private hospitals (48% against 34%).